Towards a minimally invasive approach of atypical lipomatous tumors: the MINIMALIST trial

Erasmus MC Cancer Institute0 个研究点目标入组 238 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

暂无简介。

•Aged =18 years
•-Primary or recurrent lipomatous tumor suspected for lipoma or atypical lipomatous tumor
•-Adequate understanding of the Dutch or English language (to fill out the HRQoL questionnaires)

•-Tumor localization in the mediastinum, retroperitoneum or testis/scrotum
•-Diagnosis through excisional biopsy
•-Any type of treatment for the current tumor (i.e. in case of recurrence, treatment of the prior tumor(s) is allowed)
•-Signs/suspicion of dedifferentiation in the biopsy specimen at time of diagnosis
•-Unable to undergo regular MRI-scans (for example because of a pacemaker, claustrophobia)
•-Systemic treatment for any other concurrent malignancy
•-Currently receiving radiotherapy at affected site for other concurrent disease
•-Incapable to understand the study, to sign informed consent or to fill out the HRQoL-questionnaires

发起方

Erasmus MC Cancer Institute